Stock listing

NASDAQ:REPH Recro Pharma Inc Stock

Follow Recro Pharma Inc into a list and get an email when it puts out news.

Delisted NASDAQ:REPH no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:REPH
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Recro Pharma Inc on 6ix

Calls
3 calls with a replay · 3 with a transcript · latest Mar 1, 2022

Where Recro Pharma Inc is listed

ListingExchangeCountryCurrency
NASDAQ:REPH · This page · DelistedNASDAQUnited StatesUSD
NASDAQ:REPHV · DelistedNASDAQUnited StatesUSD
NASDAQ:SCTL · DelistedNASDAQUnited StatesUSD

Events

CallWhenStatus
Recro Pharma (REPH) Q4 2021 Earnings CallTue, Mar 01, 2022 · 4:30 PM ETReplay
Recro Pharma (REPH) Q3 2021 Earnings CallTue, Nov 09, 2021 · 4:30 PM ETReplay
Recro Pharma (REPH) Q2 2021 Earnings CallMon, Aug 09, 2021 · 4:30 PM ETReplay

Open Events

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Bryan M Reasons
Other companies: Mallinckrodt Inc (EVP & CFO · Since at least Mar 18, 2019); Amneal Pharmaceuticals, Inc. (CFO · May 4, 2018 – Aug 21, 2018 · Past); Aclaris Therapeutics, Inc. (Director · Apr 20, 2018 – Jun 1, 2024 · Past); Impax Laboratories Inc (Chief Financial Officer · Apr 13, 2013 – May 4, 2018 · Past)
Director · Mar 3, 2017 – Apr 8, 2024 · Past
William Ashton
Other companies: Medicus Pharma Ltd. (Director · Since at least Dec 31, 2024); Spectrum Pharmaceuticals Inc (Director · Feb 23, 2018 – Jul 31, 2023 · Past); SELLAS Life Sciences Group, Inc. (Director · Oct 10, 2017 – Oct 10, 2017 · Past)
Director · May 4, 2018 – Apr 8, 2024 · Past
Jyrki Mattila
Other companies: BioSpecifics Technologies Corp (Director · Mar 15, 2018 – May 22, 2019 · Past); Lipocine Inc. (Chief Business Officer · Jan 5, 2016 – Jan 26, 2017 · Past)
Executive VP, Business Dev. · Aug 21, 2017 – Jan 2, 2018 · Past
Mathew Paul Arens
Other companies: Health Catalyst, Inc (Director · Since at least Dec 1, 2025)
Director · Aug 23, 2023 – Apr 8, 2024 · Past
Ryan D. Lake
Other companies: Lifecore Biomedical, Inc. (Chief Financial Officer · Since at least Sep 3, 2024)
Chief Financial Officer · Jan 2, 2018 – Apr 8, 2024 · Past
Donna NicholsCAO/Controller · Mar 6, 2014 – Jan 18, 2017 · Past
Elena CantDirector · Sep 1, 2022 – Apr 8, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Recro Pharma Inc.